Bormioli Pharma, a global producer in the pharma packaging market, will attend Pharmapack Europe. The firm’s management will be on hand at the booth A66 of the fair to meet the stakeholders and discuss the company’s growth plans and innovative projects.
In a pharmaceutical market in which the drive for change is getting increasingly stronger, the company is implementing a five-year strategic plan, that has among its pillars – together with the company’s internationalization, the enhancement of efficiency of existing platforms and the increase of productivity - the design of a new model of innovation, a considerable drive that leverages on four columns:
- A more open, distributed approach, integrating internal R&D projects with start-ups and incubators – such as Le Village by Crédit Agricole – and involving clients and final users to achieve a big impact from true innovations
- A new disruptive corporate structure, unifying marketing and innovation functions to better intercept the needs and trends of the market and to ensure a faster go-to-market
- A growing attention to intercept new consumers’ needs – putting patients at the center of the stage - and external trends, such as digital and sustainability.
- Presenting the products in a new, innovative way. A first example will be shown at Pharmapack Europe, with a brand-new experience offered to visitors with an interactive installation curated by the Italian architect and innovator Carlo Ratti.
The new brand identity – unveiled for the first time during PharmaPack Europe - will be the manifesto of this new Bormioli Pharma, giving life to the very concept that animates everyday’s company behavior: Small part, Big impact. This means striving for perfection and continue innovation, aware that the difference between a great success and failure stays in detail, always with the aim of putting the health in the hands of patients.
